Dr. Paul K. Maciejewski's lab focuses on improving end-of-life care for patients with advanced cancer by addressing their spiritual needs. The lab investigates how integrating healthcare chaplains and faith community support can enhance patients' spiritual wellness and ultimately lead to better decision-making and care at the end of life. By conducting controlled trials and qualitative interviews, the lab seeks to understand the impact of spiritual care on patients' experiences in oncology settings.

The research lab led by Dr. Anant Madabhushi at Emory University focuses on using advanced imaging and computational techniques to improve cancer treatment outcomes. The lab's projects aim to develop innovative tools that predict patient responses to immunotherapy, identify risks associated with prostate cancer, and assess treatment needs for oral cavity cancers. By analyzing tissue images and using machine learning, they strive to enhance precision medicine in oncology.

Dr. Guillaume Madelin's lab at NYU School of Medicine focuses on using advanced MRI techniques to better understand and treat joint and breast conditions. Their research aims to develop new imaging methods that can monitor joint health after injuries, such as ACL tears, and assess tumor response during breast cancer treatments. By combining different MRI modalities, they hope to predict outcomes and optimize therapies for patients.

Dr. Riccardo Lattanzi's research lab focuses on enhancing Magnetic Resonance Imaging (MRI) technology through innovative software and design techniques. The lab works on optimizing radiofrequency coils essential for MRI, aiming to improve imaging quality and efficiency. They also develop open-source platforms like Cloud MR to make MRI research more accessible and educational for users around the world.

Dr. Anita Mahadevan-Jansen's lab focuses on developing imaging technologies to improve surgical outcomes, especially in pediatric patients. One major project uses near infrared autofluorescence to help surgeons identify parathyroid glands during thyroid surgeries, reducing the risk of complications like hypocalcemia. Another area of research involves using Raman spectroscopy to study changes in cervical tissue during pregnancy, aiming to better understand the biochemical and structural processes that can lead to premature birth.

Dr. David J. Marcinek's lab at the University of Washington focuses on understanding how aging affects mitochondria, which are crucial for energy production in our cells. By studying changes in mitochondrial function and their impact on heart and muscle health, the lab aims to develop interventions that could improve quality of life for older adults. Current projects investigate the role of specific protein interactions in aging and the effects of natural supplements like urolithin A on cardiac function.

Dr. Stephanie Markovina's lab focuses on improving treatment outcomes for cervical cancer, which remains a significant health challenge. By studying the role of a protein called SERPINB3, the lab aims to understand how certain tumor cells become resistant to radiation and chemotherapy and to develop new treatment strategies. Their research combines laboratory techniques with clinical trials to offer more effective, personalized treatment options for patients.

Dr. Graeme F. Mason's lab at Yale University studies how alcohol affects brain metabolism, particularly the role of acetate, a byproduct of alcohol, in energy use and stress responses. The research aims to understand how acetate influences brain structure and behavior in individuals who drink alcohol, including heavy and dependent drinkers. The lab also explores potential therapeutic interventions for alcohol dependence, focusing on metabolic adaptations and brain health.

Dr. Beatriz Penalver Bernabe's lab focuses on understanding how maternal gut microorganisms affect perinatal depression, a condition that can impact mothers and infants significantly. By studying the interactions between maternal biological systems and gut bacteria, the lab aims to uncover predictive markers for depression during and after pregnancy. This research not only seeks to enhance knowledge about mental health but also aims to improve treatment and prevention strategies for affected women, particularly from marginalized groups.

Dr. Alan Blair McMillan's lab at the University of Wisconsin-Madison focuses on understanding how chronic epilepsy affects brain aging and cognitive health in older adults. By using advanced neuroimaging techniques, the lab aims to identify specific biomarkers that indicate accelerated brain aging in individuals with this condition. The research could reveal risk and resilience factors that influence cognitive outcomes, ultimately providing insights into potential protective strategies for aging patients with epilepsy.

Dr. Jennifer A McNab's lab focuses on improving the treatment options for patients with epilepsy, especially those who do not show visible brain lesions using traditional imaging methods. By developing advanced diffusion MRI techniques, the lab aims to accurately locate the areas in the brain where seizures originate, helping neurosurgeons target these areas more effectively. The research could significantly enhance the chances of successful surgery for epilepsy patients, leading to better outcomes and potentially curative treatments.

Dr. Guobao Wang's lab focuses on advancing medical imaging techniques to improve the assessment of blood flow and metabolism in various diseases. They aim to streamline PET imaging by developing methods that leverage a single tracer to simultaneously capture vital physiological information, which could greatly enhance clinical applications and patient care. By reducing the need for multiple radiotracers, their work simplifies the imaging process and opens new avenues for research and clinical diagnostics.

Dr. Peter B. Noel's lab focuses on improving medical imaging technologies, particularly in the area of computed tomography (CT) and x-ray imaging. They are developing innovative approaches, such as 3D printing patient-specific CT phantoms to enhance the accuracy of imaging devices. Additionally, they are researching advanced imaging techniques to detect early changes in lung structure due to radiation therapy, with the aim of improving patient care outcomes.

Dr. Xueyan Mei's lab at the Icahn School of Medicine focuses on improving the diagnosis and management of multiple myeloma, a type of blood cancer, using advanced imaging techniques and artificial intelligence. By developing deep learning models, the lab aims to automate the analysis of medical images to better assess disease progression and tailor treatment for patients. The research combines cutting-edge imaging technologies with clinical data to enhance patient outcomes in a field where effective prognostication can greatly influence treatment strategies.

Loren K. Mell's lab focuses on improving treatment options for head and neck cancer patients, especially those who are medically unfit for standard therapies. The lab conducts clinical trials to develop novel therapeutic strategies for older adults and underserved populations, ensuring these groups are well-represented in research. They seek to improve patient outcomes through innovative risk assessment methods and mentorship of emerging investigators in the field.

Dr. Richard E. Carson's lab focuses on developing innovative radioligands for positron emission tomography (PET) to advance our understanding of mental health disorders. They explore the role of various molecular targets, such as receptors and transporters in the brain, that are implicated in conditions like depression and schizophrenia. By validating these radioligands, the lab aims to improve the diagnosis and treatment of mental health issues and contribute to the broader field of molecular neuroscience.

Dr. Jiang He's lab at the University of Virginia focuses on developing new imaging and treatment methods for mesothelioma, a challenging form of cancer. The lab is working on a human monoclonal antibody that targets a specific tumor marker found in various mesothelioma subtypes. By using advanced imaging techniques, such as SPECT, and targeted alpha therapy, they aim to improve treatment outcomes for patients, especially for those suffering from difficult-to-treat forms of the disease.

Dr. Kavindra Nath's lab at the University of Pennsylvania focuses on improving cancer treatment monitoring through advanced imaging techniques. They study how targeted therapies, particularly those affecting metabolism in cancer cells, can be evaluated non-invasively. By analyzing metabolic changes in cancer cells, specifically in diffuse large B-cell lymphoma, the lab aims to provide earlier assessments of treatment effectiveness without the need for invasive procedures like biopsies.

Dr. Jiahe Li's lab focuses on developing innovative microbial-based treatments for colorectal cancer, specifically targeting harmful metabolites produced by gut bacteria. They aim to understand how engineered non-pathogenic bacteria can neutralize a carcinogenic substance called colibactin, which is linked to cancer progression. The research combines microbiology with cancer biology to explore new therapeutic strategies for combating this disease.

Dr. Michael Fischbach's lab at Stanford University focuses on harnessing the power of the human microbiome to create innovative vaccines. By engineering certain beneficial bacteria to target diseases like cancer and autoimmune conditions, the lab aims to develop solutions that are effective, durable, and easy to distribute, particularly in low-resource settings. This research combines cutting-edge technologies from immunology and microbiology to redefine how vaccines can be designed and applied.